Prescription Required
Inclusive of all taxes
In Nausea Lupisetron Plus 4 mg/500 mg Tablet blocks the action of chemicals in the body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused due to some medicines or cancer treatment. This medicine helps you recover more comfortably from cancer treatments such as radiation therapy or chemotherapy. It is also effective at preventing nausea and vomiting after an operation (in adults only). The dose will depend on what you are being treated for but always take this medicine as it is prescribed.
It is unsafe to consume alcohol with Lupisetron Plus 4 mg/500 mg Tablet.
Lupisetron Plus 4 mg/500 mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Lupisetron Plus 4 mg/500 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Lupisetron Plus 4 mg/500 mg Tablet does not usually affect your ability to drive.
Lupisetron Plus 4 mg/500 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Lupisetron Plus 4 mg/500 mg Tablet may be needed. Please consult your doctor. However, Lupisetron Plus 4 mg/500 mg Tablet contains paracetamol which is considered the safest painkiller for kidney disease patients.
Lupisetron Plus 4 mg/500 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Lupisetron Plus 4 mg/500 mg Tablet may be needed. Please consult your doctor. However, the use of Lupisetron Plus 4 mg/500 mg Tablet is not recommended in patients with severe liver disease and active liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Captab Biotec || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Moraceae Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)